Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medicine Induced Hemodialysis for SARS-CoV-2 Spike Protein Immune Attacks
NCT05711810Phase 4Completed
- Start
- Jan 2023
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lansoprazole in myocarditis and Coronavirus Disease 2019 (COVID-19). Primary endpoints: Heart Rate at 1 day, Electrocardiogram at 20 days and 4 more. Started Jan 2023; status: completed.
02
Drugs
lansoprazole
03
Conditions
myocarditisCoronavirus Disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05711810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05711810.